Q3 Earnings Forecast for Oxbridge Re Issued By Maxim Group

Oxbridge Re Holdings Limited (NASDAQ:OXBR) – Analysts at Maxim Group cut their Q3 2026 earnings estimates for shares of Oxbridge Re in a research report issued on Monday, August 17th. Maxim Group analyst A. Klee now anticipates that the insurance provider will post earnings per share of ($0.06) for the quarter, down from their prior estimate of ($0.05). Maxim Group has a “Buy” rating and a $3.00 price target on the stock. The consensus estimate for Oxbridge Re’s current full-year earnings is ($0.04) per share. Maxim Group also issued estimates for Oxbridge Re’s Q4 2026 earnings at ($0.04) EPS, FY2026 earnings at ($0.08) EPS, Q1 2027 earnings at ($0.07) EPS, Q3 2027 earnings at ($0.07) EPS, Q4 2027 earnings at ($0.07) EPS and FY2027 earnings at ($0.18) EPS.

Oxbridge Re (NASDAQ:OXBR) last posted its quarterly earnings data on Thursday, August 13th. The insurance provider reported $0.02 earnings per share for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.01). Oxbridge Re had a return on equity of 2.14% and a net margin of 4.71%.The company had revenue of $0.94 million for the quarter, compared to analyst estimates of $1.10 million.

A number of other brokerages have also issued reports on OXBR. Weiss Ratings raised Oxbridge Re from a “sell (d-)” rating to a “sell (d+)” rating in a research note on Friday. Zacks Research raised shares of Oxbridge Re to a “hold” rating in a research note on Wednesday, June 17th. One analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $3.00.

Oxbridge Re Trading Down 1.5%

Shares of Oxbridge Re stock opened at $1.35 on Wednesday. Oxbridge Re has a twelve month low of $0.66 and a twelve month high of $2.86. The firm has a market capitalization of $10.94 million, a PE ratio of 67.53 and a beta of 1.94. The firm’s 50-day moving average price is $1.30 and its 200 day moving average price is $1.07.

Institutional Trading of Oxbridge Re

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Virtu Financial LLC acquired a new stake in Oxbridge Re during the third quarter worth $32,000. International Assets Investment Management LLC lifted its stake in shares of Oxbridge Re by 61.2% in the 1st quarter. International Assets Investment Management LLC now owns 48,000 shares of the insurance provider’s stock valued at $54,000 after purchasing an additional 18,227 shares during the last quarter. Finally, J.W. Cole Advisors Inc. lifted its stake in shares of Oxbridge Re by 106.1% in the 4th quarter. J.W. Cole Advisors Inc. now owns 68,000 shares of the insurance provider’s stock valued at $90,000 after purchasing an additional 35,000 shares during the last quarter. Institutional investors and hedge funds own 5.64% of the company’s stock.

Oxbridge Re Company Profile

Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.

The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.